Funding Formulas Overview and Examples Gail Bolan Director, Division of STD Prevention Harrell Chesson Health Economist Considerations for the FY2014 STD.

Slides:



Advertisements
Similar presentations
STD Epidemiology in Texas Changes in STD Data Presentation Previous STD slide set data were presented using STD cases based on the report date.
Advertisements

Sexually Transmitted Disease (STD) Surveillance Report, 2010
Sexually Transmitted Disease Surveillance 2012 Division of STD Prevention.
Hispanic population in Virginia STD Trends Data through 2006.
STD Screening in HIV Clinics: Value and Implications Thomas Farley, MD MPH Tulane University Deborah Cohen, MD MPH RAND Corporation.
Syphilis Trends in the United States James D. Heffelfinger, MD, MPH Epidemiology and Surveillance Branch, DSTD Centers for Disease Control and Prevention.
National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of HIV/AIDS Prevention Epidemiology of HIV Infection through 2012.
SOUTH CAROLINA EPIDEMIOLOGIC PROFILE Data available in an Integrated Epidemiologic Profile Core Epi Section Socio-demographic characteristics of.
STDs and HIV Among Youth in Nevada
HIV Surveillance – Persons Who Inject Drugs National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of HIV/AIDS Prevention.
HIV Surveillance by Race/Ethnicity National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of HIV/AIDS Prevention.
STDs in Adolescents and Young Adults Sexually Transmitted Disease Surveillance 2009 Division of STD Prevention.
The CDC Prevention Grant Funding Opportunity Announcement (FOA) and OA’s Response Overview and Discussion September 21, 2011 California Department of Public.
Florida Department of Health HIV/AIDS & Hepatitis Section Annual data trends as of 12/31/2012 Living (Prevalence) data as of 05/16/2012 Epidemiology of.
HIV/AIDS Prevention Committee Public Meeting November 21, 2013.
Florida Department of Health HIV/AIDS Section Division of Disease Control and Health Protection Annual data trends as of 12/31/2013 Living (Prevalence)
Houston/Harris County HIV Epidemiology Bureau of HIV/STD and Viral Hepatitis Prevention June 2013.
1 HIV/STD Trends in Texas Sharon K. Melville, M.D., M.P.H. Texas Department of State Health Services Texas Public Health Association April 22, 2010.
Maps Based on Data from 2013 HIV Surveillance Report (through 2013) National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of HIV/AIDS.
Linking STD and HIV Morbidity and Risk Behaviors in Indiana James D. Beall, MA Sr. Public Health Advisor Indiana State Department of Health.
STDs in Women and Infants Sexually Transmitted Disease Surveillance 1998 Division of STD Prevention.
HIV/STD Epidemiology in Oklahoma HIV/STD Service Division of Prevention and Preparedness Oklahoma State Department of Health.
Illinois Higher Education FY15 Performance Funding Recommendations IBHE Board Presentation February 4, 2014 Dr. Alan Phillips.
The Youth Risk Behavior Surveillance System (YRBSS): 2013 The Youth Risk Behavior Surveillance System (YRBSS): 2013 National, State, and Local Data National.
Program Collaboration and Service Integration: An NCHHSTP Green paper Kevin Fenton, M.D., Ph.D., F.F.P.H. Director National Center for HIV/AIDS, Viral.
Program Collaboration and Service Integration Surveillance and Strategic Information Kevin Fenton, M.D., Ph.D., F.F.P.H. Director National Center for HIV/AIDS,
STDs in Adolescents and Young Adults Sexually Transmitted Disease Surveillance 2003 Division of STD Prevention.
Racial Disparities in Antiretroviral Therapy Use and Viral Suppression among Sexually Active HIV-infected Men who have Sex with Men— United States, Medical.
2013 Update Illustrating HIV/AIDS in the United States Virginia.
Sexually Transmitted Disease (STD) Surveillance Report, 2009 Minnesota Department of Health STD Surveillance System Minnesota Department of Health STD.
Sexually Transmitted Infections Mysheika Williams Roberts, MD, MPH Medical Director Assistant Health Commissioner Columbus.
Division of HIV/AIDS Prevention CDC-RFA-PS
2011 STD Surveillance Update. Successful Prevention of STDs Est. 19 million STIs in the U.S. each year costing $12 - $20 billion in lifetime direct medical.
Kevin Fenton, MD, PhD National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention August 5, 2008 Update on the US HIV/AIDS Crisis: Current Trends,
Welcome to “STD 101 in a Box” Developed by Centers for Disease Control and Prevention National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
 2012 NCCI Holdings, Inc. WC-5 Just How Credible Is That Employer? Proposed Experience Rating Plan Changes CAS RPM Seminar Philadelphia, PA March 21,
The Youth Risk Behavior Surveillance System (YRBSS): 2011 The Youth Risk Behavior Surveillance System (YRBSS): 2011 National, State, and Local Data National.
Introduction to NCHHSTP National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Office of the Director Jonathan Mermin, MD, MPH National.
2014 HIV.STD.TB.Viral Hepatitis Symposium. Program Staff Lindsey VanderBusch – Program Manager Sarah.
Sexually Transmitted Disease (STD) Surveillance Report, 2013 Minnesota Department of Health STD Surveillance System Minnesota Department of Health STD.
STDs in Adolescents and Young Adults Sexually Transmitted Disease Surveillance 1998 Division of STD Prevention.
Sexually Transmitted Disease (STD) Surveillance Report, 2008 Minnesota Department of Health STD Surveillance System Minnesota Department of Health STD.
STDs in Adolescents and Young Adults Sexually Transmitted Disease Surveillance 1999 Division of STD Prevention.
Presentation to: Presented by: Date: STD 2013 Data Update Georgia Legislative Black Caucus Michelle Allen 2/10/15.
HIV/STD Partner Services Recommendations Cindy Getty & Rheta Barnes Divisions of HIV/AIDS Prevention & STD Prevention National Centers for HIV/AIDS, Viral.
Florida Department of Health HIV/AIDS Section Division of Disease Control and Health Protection Annual data trends as of 12/31/2014 Living (Prevalence)
HIV Surveillance in Urban and Nonurban Areas through 2013 National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of HIV/AIDS Prevention.
STD’s in Adolescents and Young Adults Sexually Transmitted Disease Surveillance 2001 Division of STD Prevention.
West Virginia Office of Epidemiology and Prevention Services 1 Gonorrhea Morbidity in West Virginia Caroline A. Williams, MD, Director Division of STD,
STDs in Women and Infants Sexually Transmitted Disease Surveillance 2009 Division of STD Prevention.
HIV Surveillance by Race/Ethnicity
Chapter 13 Personal Wellness Sexually Transmitted Diseases Pages
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Sexually Transmitted Disease Prevention.
STDs in Racial and Ethnic Minorities Sexually Transmitted Disease Surveillance 2003 Division of STD Prevention.
HIV Surveillance in Women National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of HIV/AIDS Prevention.
STDs in Women and Infants Sexually Transmitted Disease Surveillance 2008 Division of STD Prevention.
STDs in Persons Entering Corrections Facilities Sexually Transmitted Disease Surveillance 1999 Division of STD Prevention.
STDs in Women and Infants Sexually Transmitted Disease Surveillance 2007 Division of STD Prevention.
STDs in Adolescents and Young Adults Sexually Transmitted Disease Surveillance 2005 Division of STD Prevention.
STDs in Adolescents and Young Adults Sexually Transmitted Disease Surveillance 2004 Division of STD Prevention.
Santa Barbara County STD Summary Report Improve the health of our communities by preventing disease, promoting wellness, and ensuring access.
Coastal Bend and State Population % Distribution by Age Groups 2000
HIV Surveillance in Adolescents and Young Adults
Illustrating HIV/AIDS in the United States
Sexually Transmitted Disease (STD) Surveillance Report, 2016
HIV Prevention Data Amanda Dennison, MPH Ohio Department of Health
The Youth Risk Behavior Surveillance System (YRBSS): 2013
STD’S: VIRAL OR BACTERIAL
The Youth Risk Behavior Surveillance System (YRBSS): 2011
Coastal Bend and State Population % Distribution by Age Groups 2000
Presentation transcript:

Funding Formulas Overview and Examples Gail Bolan Director, Division of STD Prevention Harrell Chesson Health Economist Considerations for the FY2014 STD Program FOA Funding Formula Division of STD Prevention Webinar August 30, 2012 National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of STD Prevention

Overview  Rationale for formula-based funding  Purpose of the webinar  Gain input on factors to include in the formula and implementation of the formula  Describe elements under consideration  Factors to include and why  Potential adjustments and why  Provide generic examples of how a funding formula would work  Discussion and follow-up

Rationale for Formula-based Funding  Goals of formula-based funding  Fairness of resource allocation  Allocation of funds to align with burden of disease  Development of formulas is preliminary  Potential factors to include in formulas Population, burden of disease (actual or expected), social determinants, & quality of program  Potential adjustments to funding formulas Funding minimum (floor), caps on increases and decreases in funding, phase-in of new funding allocations

Funding Formulas  Potential Factors to Include in Formulas  Population  Burden of Disease  Social Determinants of Health  Quality of Program  Potential Adjustments to Funding Formulas  Funding minimum (floor)  Maximum reductions and increases in funding  Phase-in of new funding allocations

Funding Formulas  Potential Factors to Include in Formulas  Population  Burden of Disease  Social Determinants of Health  Quality of Program  Potential Adjustments to Funding Formulas  Funding minimum (floor)  Maximum reductions and increases in funding  Phase-in of new funding allocations

Population  Funding can depend on size of population and subpopulations  Examples of subpopulations:  Ages  Ages  MSM  People living with HIV  Population groups can be weighted according to DSTDP priorities

Hypothetical Example of Population Weights  2 states (A & B)  $500,000 to allocate based on population  Example weights for population  1 for overall population  10 for MSM

Hypothetical Example of Population Weights  2 states (A & B)  $500,000 to allocate based on population  Example weights for population  1 for overall population  10 for MSM StateTotal PopMSM PopTot pop score MSM pop score Total score A200, B100,00010,000100, ,000

Hypothetical Example of Population Weights  2 states (A & B)  $500,000 to allocate based on population  Example weights for population  1 for overall population  10 for MSM StateTotal PopMSM PopTot pop score MSM pop score Total score A200, B100,00010,000100, ,000

Hypothetical Example of Population Weights  2 states (A & B)  $500,000 to allocate based on population  Example weights for population  1 for overall population  10 for MSM StateTotal PopMSM PopTot pop score MSM pop score Total score A200, B100,00010,000100, ,000

Hypothetical Example of Population Weights  2 states (A & B)  $500,000 to allocate based on population  Example weights for population  1 for overall population  10 for MSM StateTotal PopMSM PopTot pop score MSM pop score Total score A200, B100,00010,000100, ,000 In this example, both states would get equal amounts of funding ($250,000 each) because their “weighted” populations are equal

Funding Formulas  Potential Factors to Include in Formulas  Population  Burden of Disease  Social Determinants of Health  Quality of Program  Potential Adjustments to Funding Formulas  Funding minimum (floor)  Maximum reductions and increases in funding  Phase-in of new funding allocations

Burden of Disease  Funding can depend on burden of disease  Chlamydia  Gonorrhea  Syphilis  STDs can be weighted according to DSTDP priorities  Higher weight on syphilis in females would reflect priority of congenital syphilis  Higher weight on syphilis in males would reflect priority of MSM  Higher weights on chlamydia would reflect priority of adolescents and young adults, reproductive health

Hypothetical Example of Disease Burden Weights  3 states (A, B, C)  $350,000 to allocate based on disease burden  Example weights for disease  5 for syphilis  1 for gonorrhea

Hypothetical Example of Disease Burden Weights  3 states (A, B, C)  $350,000 to allocate based on disease burden  Example weights for disease  5 for syphilis  1 for gonorrhea StateGC casesP & S cases GC score P & S score Total score Share of burden Funding A010555/35$50,000 B /35$100,000 C /35$200,000 Total /35$350,000

Hypothetical Example of Disease Burden Weights  3 states (A, B, C)  $350,000 to allocate based on disease burden  Example weights for disease  5 for syphilis  1 for gonorrhea StateGC casesP & S cases GC score P & S score Total score Share of burden Funding A010555/35$50,000 B /35$100,000 C /35$200,000 Total /35$350,000

Hypothetical Example of Disease Burden Weights  3 states (A, B, C)  $350,000 to allocate based on disease burden  Example weights for disease  5 for syphilis  1 for gonorrhea StateGC casesP & S cases GC score P & S score Total score Share of burden Funding A010555/35$50,000 B /35$100,000 C /35$200,000 Total /35$350,000

Hypothetical Example of Disease Burden Weights  3 states (A, B, C)  $350,000 to allocate based on disease burden  Example weights for disease  5 for syphilis  1 for gonorrhea StateGC casesP & S cases GC score P & S score Total score Share of burden Funding A010555/35$50,000 B /35$100,000 C /35$200,000 Total /35$350,000

Hypothetical Example of Disease Burden Weights  3 states (A, B, C)  $350,000 to allocate based on disease burden  Example weights for disease  5 for syphilis  1 for gonorrhea StateGC casesP & S cases GC score P & S score Total score Share of burden Funding A010555/35$50,000 B /35$100,000 C /35$200,000 Total /35$350,000

Hypothetical Example of Disease Burden Weights  3 states (A, B, C)  $350,000 to allocate based on disease burden  Example weights for disease  5 for syphilis  1 for gonorrhea StateGC casesP & S cases GC score P & S score Total score Share of burden Funding A010555/35$50,000 B /35$100,000 C /35$200,000 Total /35$350,000

Hypothetical Example of Disease Burden Weights  3 states (A, B, C)  $350,000 to allocate based on disease burden  Example weights for disease  5 for syphilis  1 for gonorrhea StateGC casesP & S cases GC score P & S score Total score Share of burden Funding A010555/35$50,000 B /35$100,000 C /35$200,000 Total /35$350,000

Burden of Disease  Burden of disease can also be based on “expected” burden rather than “actual burden”  Example of expected burden based on racial distribution of population  Gonorrhea rate = % white x (national rate in whites) + % black x (national rate in blacks) + additional populations

Funding Formulas  Potential Factors to Include in Formulas  Population  Burden of Disease  Social Determinants of Health  Quality of Program  Potential Adjustments to Funding Formulas  Funding minimum (floor)  Maximum reductions and increases in funding  Phase-in of new funding allocations

Social Determinants of Health  Funding formulas could include measures of social determinants, such as  Poverty rate  Number of people in poverty  Violent crime rate  Number of violent crimes  High school graduation rate

Violent crime Poverty Unemployment Higher correlation Lower correlation

Funding Formulas  Potential Factors to Include in Formulas  Population  Burden of Disease  Social Determinants of Health  Quality of Program  Potential Adjustments to Funding Formulas  Funding minimum (floor)  Maximum reductions and increases in funding  Phase-in of new funding allocations

Quality of Program  Funding formulas could allow for project areas to receive additional resources to reward quality  Based on quality of application or other factors  Competition for additional funding could be stratified  For example: small states, medium states, large states, and cities So that smaller states do not compete with larger states

Funding Formulas  Potential Factors to Include in Formulas  Population  Burden of Disease  Social Determinants of Health  Quality of Program  Potential Adjustments to Funding Formulas  Funding minimum (floor)  Maximum reductions and increases in funding  Phase-in of new funding allocations

Funding Formula Weights  Weights can be applied within these factors  Examples were provided on previous slides Population weights o General population = 1, MSM = 10  Weights can be applied across these factors  Example Population: 30% Burden of Disease: 40% Social Determinants of Health: 20% Quality of Program: 10%

Funding Formula Weights  Weights can be applied within these factors  Examples were provided on previous slides Population weights o General population = 1, MSM = 10  Weights can be applied across these factors  Example Population: 30% Burden of Disease: 40% Social Determinants of Health: 20% Quality of Program: 10% Reminder: All examples presented today are for illustrative purposes only

Funding Formulas  Potential Factors to Include in Formulas  Population  Burden of Disease  Social Determinants of Health  Quality of Program  Potential Adjustments to Funding Formulas  Funding minimum (floor)  Maximum reductions and increases in funding  Phase-in of new funding allocations

Minimum funding  Tiered system (multiple floors)  Example: 3 levels (low, medium, high) based on population or burden of disease  Single floor (applied to all)  Example: All project areas are guaranteed of receiving at least $200,000

Maximum reductions and increases in funding  Maximum reduction in funding  Decreases in funding can be limited Example: a “cap” of 25% can be applied so that every project area’s formula-based funding allocation is equal to at least 75% of their pre-formula allocation  Maximum increase in funding  Increases in funding can be limited Based on maximum percentage gain or maximum absolute gain

Phase-in of new funding allocations  New funding allocations can be phased-in over a number of years  Example: A reduction of funding of 20% could be phased-in over 4 years: 5% in year 1, 10% in year 2, 15% in year 3, & 20% in year 4  New funding allocations could be delayed  Example: Formula-based funding is implemented in year 2 to allow 1 year of preparation for funding changes

Summary  Goals of formula-based funding  Fairness of resource allocation  Allocation of funds to align with burden of disease  Development of formulas is preliminary  Potential factors to include in formulas Population, burden of disease (actual or expected), social determinants, & quality of program  Potential adjustments to funding formulas Funding minimum (floor), caps on increases and decreases in funding, phase-in of new funding allocations

Questions and Discussion Thank you National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of STD Prevention